Effects of vasodilators on haemodynamic coherence

Area of Science:

• Cardiovascular Physiology
• Pharmacology
• Critical Care Medicine

Background:

• Microcirculatory disorders can persist despite standard hemodynamic support.
• Vasodilators offer potential therapeutic benefits by improving microvascular flow.
• Inodilators, combining vasodilation with inotropy, are particularly promising.

Purpose of the Study:

• To review the impact of vasodilators and inodilators on hemodynamic coherence.
• To assess their role in treating shock and microvascular dysfunction.
• To evaluate current evidence for their routine use.

Main Methods:

• Literature review of vasodilators (nitroglycerin, calcium antagonists, prostaglandins) and inodilators (dobutamine, phosphodiesterase-inhibitors, levosimendan).
• Analysis of their effects on hemodynamic coherence and microvascular function.
• Evaluation of clinical trial data and expert recommendations.

Main Results:

• No definitive evidence currently supports routine vasodilator use in shock.
• Venous vasodilation may reduce edema, while arteriolar vasodilation can enhance flow.
• Inodilators show promise but require further investigation.
• Microvascular monitoring is essential for guiding therapy in selected cases.

Conclusions:

• Current evidence does not support routine vasodilator therapy for microvascular dysfunction.
• Vasodilators may be considered in select patients with careful monitoring.
• Further clinical trials are needed to establish efficacy and optimal use.